Acute NSAID-related transmural duodenitis and extensive duodenal ulceration

Clinical Therapeutics

Volumn 29, Issue 11, 2007, Pages 2448-2452

  Hashash, Jana G ^a   Atweh, Lamya A ^a   Saliba, Teddy ^a   Chakhachiro, Zaher ^a   Al Kutoubi, Aghiad ^a   Tawil, Ayman ^a   Barada, Kassem A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

duodenal ulcer; NSAIDs

Indexed keywords

AMYLASE; NONSTEROID ANTIINFLAMMATORY AGENT; RABEPRAZOLE; TIAPROFENIC ACID; TRIACYLGLYCEROL LIPASE;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADULT; ALCOHOL CONSUMPTION; AMYLASE BLOOD LEVEL; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CELL DEATH; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG USE; DUODENITIS; DUODENUM ULCER; EMERGENCY WARD; EOSINOPHIL; EROSION; GASTRITIS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAMINA PROPRIA; LIVER FUNCTION TEST; MALE; NEUTROPHIL; PEPTIC ULCER; PHYSICAL EXAMINATION; SINGLE DRUG DOSE; STOMACH ULCER; TOOTH PAIN; TRANSMURAL DUODENITIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUODENAL ULCER; DUODENITIS; ENDOSCOPY; HUMANS; INTESTINAL MUCOSA; MALE; NEUTROPHILS; PROPIONIC ACIDS; TOMOGRAPHY, X-RAY COMPUTED; TOOTHACHE;

EID: 37349080519     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.11.012     Document Type: Article

References (24)

1. Cryer B. Nonsteroidal anti-inflammatory drug injury. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Patlophysiology, Diagnosis, Management. 7 (2002), Philadelphia, Pa: Saunders 408-430
2. Fellows I., Bhaskar N., and Hawkey C. Nature and time course of piroxicam-induced injury to human gastric mucosa. Aliment Pharmacol Ther 3 (1989) 481-488
3. Wolfe M., Lichtenstein D., and Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 340 (1999) 1888-1899
4. O'Laughlin J., Hoftiezer J., and Ivey K. Effect of aspirin on the human stomach in normals: Endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration. Scand J Gastroenterol Suppl. 67 (1981) 211-214
5. Eliakim R., Ophir M., and Rachmilewitz D. Duodenal mucosal injury with nonsteroidal antiinflammatory drugs. J Clin Gastroenterol 9 (1987) 395-399
6. Singh G. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: A view from the ARAMIS database Arthritis, Rheumatism, and Aging Medical Information System. Am J Ther 7 (2000) 115-121
7. Cheatum D., Arvanitakis C., Gumpel M., et al. An endoscopic study of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs. Clin Ther. 21 (1999) 992-1003
8. Laine L., Harper S., Simon T., et al., the Rofecoxib Osteoarthritis Endoscopy Study Group. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastro-duodenal mucosa of patients with osteoarthritis. Gastroenterology 117 (1999) 776-783
9. Hawkey C., Laine L., Simon T., et al., the Rofecoxib Osteoarthritis Endoscopy Multinational Study Group. Comparison of the effect ofrofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum 43 (2000) 370-377
10. Simon L., Weaver A., Graham D., et al. Anti-inflammatory and upper gastrointestinal effects ofcelecoxib in rheumatoid arthritis: A randomized controlled trial. JAMA 282 (1999) 1921-1928
11. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 120 (2001) 594-606
12. Stoltz R., Harris S., Kuss M., et al. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects. Am J Gastroenterol. 97 (2002) 65-71
13. Donnelly M., Richardson P., Hawkey C., et al. Dose-dependent effects of ketoprofen on the human gastric mucosa in comparison with ibuprofen. Aliment Pharmacol Ther. 14 (2000) 543-549
14. Goldstein J., Aisenberg J., Lanza F., et al. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Clin Ther 28 (2006) 340-351
15. Lipscomb G., Wallis N., Armstrong G., and Rees W. Gastrointestinal tolerability of meloxicam and piroxicam: A double-blind placebo-controlled study. Br J Clin Pharmacol. 46 (1998) 133-137
16. Moberly J., Harris S., Riff D., et al. A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa. Dig Dis Sci 52 (2007) 442-450
17. Singh G., and Rosen R.D. NSAID induced gastrointestinal complications: The ARAMIS perspective 1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl 51 (1998) 8-16
18. Lanza F. Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 88 (1993) 1318-1323
19. Mahe I., Mouly S., Mahe E., et al. Endoscopic evaluation of the gastro-tolerance of short-term antalgic treatment with low dose k-diclofenac: A comparison of ibuprofen and aspirin. Fundam Clin Pharmacol. 15 (2001) 61-63
20. Jayaraman M., Mayo-Smith W., Movson J., et al. CT of the duodenum: An overlooked segment gets its due. Radiographics 21 (2001) S147-S160
21. Pictorial review. Zissin R., Osadchy A., Gayer G., and Shapiro-Feinberg M. CT of duodenal pathology. Br J Radiol 75 (2002) 78-84
22. Macari M., and Balthazar E. CT of bowel wall thickening: Significance and pitfalls of interpretation. Air Am J Roentgenol 176 (2001) 1105-1116
23. Jacobs J., Hill M., and Steinberg W. Peptic ulcer disease: CT evaluation. Radiology 178 (1991) 745-748
24. Naranjo C., Busto U., Sellers E., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 30 (1981) 239-245